down arrow

Tianjin Ringpu Bio-technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000TV1
CNY
19.27
-0.11 (-0.57%)

Dec 04

SHE

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

16.0828.90
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 16.25% and Operating profit at 10.63% over the last 5 years

 
2

Flat results in Mar 25

3

With ROE of 9.27%, it has a fair valuation with a 1.49 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 6,787 Million (Mid Cap)

stock-summary
P/E

16.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.07%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

9.27%

stock-summary
Price to Book

1.49

Revenue and Profits:
Net Sales:
878 Million
(Quarterly Results - Jun 2025)
Net Profit:
152 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.45%
0%
-9.45%
6 Months
-23.1%
0%
-23.1%
1 Year
-7.13%
0%
-7.13%
2 Years
11.45%
0%
11.45%
3 Years
-6.86%
0%
-6.86%
4 Years
-15.92%
0%
-15.92%
5 Years
-12.81%
0%
-12.81%

Tianjin Ringpu Bio-technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Tianjin Ringpu Bio-technology Co., Ltd. Reports Strong Financial Performance in Q1 2025

Tianjin Ringpu Bio-technology Co., Ltd. has showcased impressive financial results for the quarter ending March 2025, reflecting a robust growth trajectory in the pharmaceuticals and biotechnology sector. The company reported net sales of CNY 2,129.34 MM, marking a significant growth of 79.88% compared to the previous year.

In addition to strong sales figures, Tianjin Ringpu Bio-technology Co., Ltd. achieved its highest operating cash flow at CNY 751.72 MM, indicating effective cash management and operational efficiency. The company also reported a notable inventory turnover ratio of 4.57%, suggesting that it is effectively managing its inventory levels and sales processes.

Furthermore, the raw material costs have decreased by 1.09% year-over-year, which could positively impact the company's profit margins. The cash and equivalents for the half-year reach...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.25%
EBIT Growth (5y)
10.63%
EBIT to Interest (avg)
14.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.04
Sales to Capital Employed (avg)
0.46
Tax Ratio
10.67%
Dividend Payout Ratio
46.48%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.09%
ROE (avg)
9.50%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.49
EV to EBIT
15.41
EV to EBITDA
10.20
EV to Capital Employed
1.49
EV to Sales
1.85
PEG Ratio
NA
Dividend Yield
2.07%
ROCE (Latest)
9.67%
ROE (Latest)
9.27%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 7.60% vs -37.90% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 26.56% vs 82.80% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "877.80",
          "val2": "815.80",
          "chgp": "7.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "180.60",
          "val2": "172.50",
          "chgp": "4.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.20",
          "val2": "9.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "18.00",
          "val2": "25.30",
          "chgp": "-28.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "152.00",
          "val2": "120.10",
          "chgp": "26.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.90%",
          "val2": "142.70%",
          "chgp": "-0.08%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 13.30% vs 30.16% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -35.96% vs 37.77% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,043.60",
          "val2": "2,686.40",
          "chgp": "13.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "573.30",
          "val2": "517.40",
          "chgp": "10.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.00",
          "val2": "26.70",
          "chgp": "23.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-14.40",
          "val2": "56.20",
          "chgp": "-125.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "329.80",
          "val2": "515.00",
          "chgp": "-35.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "122.10%",
          "val2": "139.00%",
          "chgp": "-1.69%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
877.80
815.80
7.60%
Operating Profit (PBDIT) excl Other Income
180.60
172.50
4.70%
Interest
9.20
9.20
Exceptional Items
18.00
25.30
-28.85%
Consolidate Net Profit
152.00
120.10
26.56%
Operating Profit Margin (Excl OI)
141.90%
142.70%
-0.08%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.60% vs -37.90% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 26.56% vs 82.80% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
3,043.60
2,686.40
13.30%
Operating Profit (PBDIT) excl Other Income
573.30
517.40
10.80%
Interest
33.00
26.70
23.60%
Exceptional Items
-14.40
56.20
-125.62%
Consolidate Net Profit
329.80
515.00
-35.96%
Operating Profit Margin (Excl OI)
122.10%
139.00%
-1.69%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 13.30% vs 30.16% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -35.96% vs 37.77% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Tianjin Ringpu Bio-technology Co., Ltd. stock-summary
stock-summary
Tianjin Ringpu Bio-technology Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."